RIPTIDE Trademark

Trademark Overview

On Monday, June 13, 2022, a trademark application was filed for RIPTIDE with the United States Patent and Trademark Office. The USPTO has given the RIPTIDE trademark a serial number of 97455373. The federal status of this trademark filing is REGISTERED as of Tuesday, October 15, 2024. This trademark is owned by Zimmer, Inc.. The RIPTIDE trademark is filed in the Medical Instrument Products category with the following description:

orthopedic fixation implants composed of artificial materials, namely, foot implants designed to aid in early bone growth; none of the foregoing used in the field of neurovascular surgery or to treat neurovascular conditions
riptide

General Information

Serial Number97455373
Word MarkRIPTIDE
Filing DateMonday, June 13, 2022
Status700 - REGISTERED
Status DateTuesday, October 15, 2024
Registration Number7538284
Registration DateTuesday, October 15, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and Servicesorthopedic fixation implants composed of artificial materials, namely, foot implants designed to aid in early bone growth; none of the foregoing used in the field of neurovascular surgery or to treat neurovascular conditions

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 16, 2022
Primary Code010
First Use Anywhere DateWednesday, August 31, 2022
First Use In Commerce DateWednesday, August 31, 2022

Trademark Owner History

Party NameZimmer, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarsaw, IN 46580
Party NameZimmer, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWarsaw, IN 46580
Party NameZimmer, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarsaw, IN 46580

Trademark Events

Event DateEvent Description
Thursday, June 16, 2022NEW APPLICATION ENTERED
Thursday, June 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, March 26, 2023ASSIGNED TO EXAMINER
Thursday, March 30, 2023NON-FINAL ACTION WRITTEN
Thursday, March 30, 2023NON-FINAL ACTION E-MAILED
Thursday, March 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 13, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Friday, August 25, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, September 18, 2023ASSIGNED TO PETITION STAFF
Tuesday, September 19, 2023POST PUBLICATION AMENDMENT - ENTERED
Sunday, December 31, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, June 10, 2024USE AMENDMENT FILED
Monday, June 10, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 22, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 24, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 25, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 15, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 15, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 10, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

riptide neurovascular implants none used foregoing field surgery conditions treat growth